NO982181L - Type IX collagen and chimeras - Google Patents

Type IX collagen and chimeras

Info

Publication number
NO982181L
NO982181L NO982181A NO982181A NO982181L NO 982181 L NO982181 L NO 982181L NO 982181 A NO982181 A NO 982181A NO 982181 A NO982181 A NO 982181A NO 982181 L NO982181 L NO 982181L
Authority
NO
Norway
Prior art keywords
type
collagen
collagens
chimeras
new
Prior art date
Application number
NO982181A
Other languages
Norwegian (no)
Other versions
NO982181D0 (en
Inventor
Eero Vuorio
George Martin
Thomas B Neff
Leena Ala-Kokko
Original Assignee
Fibrogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrogen Inc filed Critical Fibrogen Inc
Publication of NO982181D0 publication Critical patent/NO982181D0/en
Publication of NO982181L publication Critical patent/NO982181L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det er beskrevet nye collagener, polynukleotidsekvenser kodende for disse nye proteinene og anvendelse av disse nye proteinene og polynukleotidene for diagnostikk og. behandling av sykdom. Det er videre beskrevet spesifikke collagener og derivater, spesielt fusjonsproteiner av type IX collagen med type II og/eller type XI collagener, og anvendelse derav som terapeutiske midler.New collagens, polynucleotide sequences coding for these new proteins and the use of these new proteins and polynucleotides for diagnostics and. treatment of disease. Specific collagens and derivatives, in particular fusion proteins of type IX collagen with type II and/or type XI collagens, and their use as therapeutic agents are further described.

NO982181A 1995-11-13 1998-05-13 Type IX collagen and chimeras NO982181L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US660895P 1995-11-13 1995-11-13
US74553996A 1996-11-12 1996-11-12
PCT/US1996/018149 WO1997017988A1 (en) 1995-11-13 1996-11-13 Type ix collagen and chimeras

Publications (2)

Publication Number Publication Date
NO982181D0 NO982181D0 (en) 1998-05-13
NO982181L true NO982181L (en) 1998-07-06

Family

ID=26675846

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982181A NO982181L (en) 1995-11-13 1998-05-13 Type IX collagen and chimeras

Country Status (7)

Country Link
EP (1) EP0861086A1 (en)
JP (1) JP2001510981A (en)
BR (1) BR9611547A (en)
CA (1) CA2237900A1 (en)
IL (1) IL124437A0 (en)
NO (1) NO982181L (en)
WO (1) WO1997017988A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773248A (en) * 1995-11-13 1998-06-30 Uab Research Foundation Nucleic acid encoding a human α3(IX) collagen protein and method of producing the protein recombinantly
AUPO331096A0 (en) * 1996-10-29 1996-11-21 Commonwealth Scientific And Industrial Research Organisation Collagen products
CA2269801A1 (en) * 1996-10-29 1998-05-07 Commonwealth Scientific And Industrial Research Organisation Stable expression of triple helical proteins
RU2002112751A (en) * 1999-11-12 2004-02-27 Файброджен, Инк. (Us) Recombinant Gelatins
WO2001036657A2 (en) * 1999-11-17 2001-05-25 Philadelphia Health & Education Corporation Altered type ix collagen gene sequences associated with intervertebral disc disease
US7268116B2 (en) * 2003-10-02 2007-09-11 Genhunter Corp. Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
CN102212126B (en) * 2010-04-08 2013-06-19 上海普洛康裕药物研究院有限公司 Recombinant EDI (Endothelial Genesis Inhibitor)-8t protein with endothelial cell growth inhibiting activity
WO2011150073A2 (en) * 2010-05-26 2011-12-01 Shriners Hospitals For Children Compositions comprising the nc2 domain of collagen ix and methods of using same
US11377490B2 (en) 2017-05-31 2022-07-05 Sichuan Clover Biopharmaceuticals, Inc Method for treating cancer using disulfide-linked trimeric 4-1BBL
CN109456989B (en) * 2018-10-31 2022-03-29 陕西慧康生物科技有限责任公司 Construction method of vector for improving secretion expression of pichia pastoris
WO2021249116A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Coronavirus vaccine compositions, methods, and uses thereof
WO2021249011A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Hiv vaccine compositions, methods, and uses thereof
WO2022041760A1 (en) 2020-08-31 2022-03-03 Sichuan Clover Biopharmaceuticals, Inc. Methods and compositions for purification of trimeric fusion proteins
CN112364726B (en) * 2020-10-27 2024-06-04 重庆大学 Part code-spraying character positioning method based on improved EAST

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3302017B2 (en) * 1991-10-23 2002-07-15 トーマス・ジェファーソン・ユニバーシティ Synthesis of human procollagen and collagen in a recombinant DNA synthesis system

Also Published As

Publication number Publication date
BR9611547A (en) 1999-06-15
MX9803801A (en) 1998-10-31
NO982181D0 (en) 1998-05-13
WO1997017988A1 (en) 1997-05-22
JP2001510981A (en) 2001-08-07
IL124437A0 (en) 1998-12-06
CA2237900A1 (en) 1997-05-22
EP0861086A1 (en) 1998-09-02

Similar Documents

Publication Publication Date Title
NO982181L (en) Type IX collagen and chimeras
IS4416A (en) Body weight modulators, corresponding nucleic acids and proteins, and their use in diagnostic and medical treatment
ATE358176T1 (en) HUMAN DNASE
NL300062I2 (en) Osteogenic agents.
DK0733109T3 (en) BMP-12, BMP-13 and late inducing preparations thereof
DE69942365D1 (en) TARGETED SUPPLY OF PHARMACEUTICAL AGENTS TO INJURED TISSUE
TR199802421T2 (en) Substances that regulate tissue regeneration.
NO974824L (en) Arteriovenous and venous transplant treatments, procedures and mixtures
DE69534180D1 (en) PROMOTER OF TIE RECEPTOR PROTEIN KINASE
FI883129A7 (en) Method for producing organized collagen structures, in particular of human origin, and corresponding organized collagen structures.
EP0770089A4 (en) FACTOR 12 OF GROWTH AND DIFFERENTIATION
ATE354638T1 (en) HUMAN TISSUE INHIBITOR OF METALLOPROTEINASE-4
NO873699D0 (en) POLYPEPTIDE SUITABLE FOR DIMENSION, TREATMENT AND DIAGNOSIS OF AUTOIMMUNE DISEASES SUCH AS ARTICLES.
DE68928728D1 (en) DIAGNOSIS OF RETINOBLASTOMA
DE3675907D1 (en) COMPOSITION AND METHOD FOR BONE RECOVERY.
FI863626A7 (en) DNA sequences, recombinant DNA molecules and methods for producing human lipocortin-like polypeptides.
ITBO930059A0 (en) PROCEDURE TO OBTAIN TISSUE REGENERATION IN PERIODENTAL DENTISTRY THERAPY.
NZ500216A (en) Beta-amyloid peptide-binding proteins and pharmaceutical use
ATE344325T1 (en) NEISSERIA LACTOFERRIN-BINDING PROTEIN
DE69737293D1 (en) NUCLEOTIDE SEQUENCE CODING FOR FLAVINMONO-OXYGENASE, CORRESPONDING PROTEIN, AND ITS USES IN DIAGNOSTICS AND THERAPY
DK0870036T3 (en) Synthetic mammalian alpha-N-acetylglucosaminidase and genetic sequences therefore encoding
DE3777359D1 (en) AMINO ACID SEQUENCE OF THE HUMAN ALPHA 2 PLASMIN INHIBITOR AND CDNS, AND GENOIC DNA CODING THIS AMINO ACID SEQUENCE.
NO864742D0 (en) DNA SEQUENCE CODING FOR HUMAN Tissue PLASMINOGEN ACTIVATOR, RECOMBINANT DNA SEQUENCE, TRANSFORMED WITH THESE AND PROCEDURE FOR PREPARING THE PLASMINOGEN ACTIVATOR.
ATE271878T1 (en) USE OF PROTEIN H AS A CYTOSTATIC AGENT
ATE326533T1 (en) HUMAN ION EXCHANGE PROTEINS AND POLYNUcleotides Encoding Therefor